Convatec Group Plc traded at 243.80 this Friday March 6th, decreasing 4.80 or 1.93 percent since the previous trading session. Looking back, over the last four weeks, Convatec Group lost 7.88 percent. Over the last 12 months, its price fell by 8.07 percent. Looking ahead, we forecast Convatec Group Plc to be priced at 251.25 by the end of this quarter and at 236.40 in one year, according to Trading Economics global macro models projections and analysts expectations.
Convatec Group Plc is a United Kingdom-based medical products and technologies company. The Company is engaged in the development, manufacture and sale of medical products, services, and technologies. It is focused on solutions for the management of chronic conditions. It markets and sells its solutions and services in four categories, such as Advanced Wound Care, Ostomy Care, Continence and Critical Care, and Infusion Care. Advanced Wound Care includes advanced dressings for the management of acute and chronic wounds resulting from ongoing conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. Ostomy Care includes devices, accessories, and personalized services for individuals with a stoma. Continence and Critical Care includes products and services for people with urinary continence issues related to spinal cord injuries and other causes. Infusion Care includes disposable infusion sets used in insulin pump therapy for people with diabetes.